Ryosuke Ogura

Niigata, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Early glucocorticoid therapy for brainstem edema associated with acute inflammatory Teflon granuloma after microvascular decompression for trigeminal neuralgia: illustrative case.

Early glucocorticoid therapy for brainstem edema associated with acute inflammatory Teflon granuloma after microvascular decompression for trigeminal neuralgia: illustrative case.

Journal: Journal of neurosurgery. Case lessons

Published: December 25, 2025

Near-Infrared Photoimmunotherapy in Brain Tumors-An Unexplored Frontier.

Near-Infrared Photoimmunotherapy in Brain Tumors-An Unexplored Frontier.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 31, 2025

Sequential and coexisting bilateral suboccipital cavernous sinus arteriovenous fistulas successfully treated with unilateral transvenous coil embolization: illustrative case.

Sequential and coexisting bilateral suboccipital cavernous sinus arteriovenous fistulas successfully treated with unilateral transvenous coil embolization: illustrative case.

Journal: Journal of neurosurgery. Case lessons

Published: February 27, 2025

Syringomyelia Associated with Magendie's Foramen Obstruction Due to Probably Congenital Gliomesenchymal Anomaly.

Syringomyelia Associated with Magendie's Foramen Obstruction Due to Probably Congenital Gliomesenchymal Anomaly.

Journal: NMC case report journal

Published: February 04, 2025

Interactive Virtual Simulation with Haptics for Neurosurgery

Interactive Virtual Simulation with Haptics for Neurosurgery

Journal: No shinkei geka. Neurological surgery

Published: March 21, 2024

Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.

Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.

Journal: Journal of neuro-oncology

Published: November 10, 2023

Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis.

Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis.

Journal: Acta neuropathologica communications

Published: October 31, 2023

Preoperative interactive virtual simulation applying three-dimensional multifusion images using a haptic device for lumbosacral lipoma.

Preoperative interactive virtual simulation applying three-dimensional multifusion images using a haptic device for lumbosacral lipoma.

Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Published: October 11, 2023

Preoperative three-dimensional multifusion imaging aiding successful microvascular decompression of a cerebellopontine angle lipoma: associated hemifacial spasm. Illustrative case.

Preoperative three-dimensional multifusion imaging aiding successful microvascular decompression of a cerebellopontine angle lipoma: associated hemifacial spasm. Illustrative case.

Journal: Journal of neurosurgery. Case lessons

Published: January 13, 2023

Diffusely Infiltrating Gliomas With Poor Prognosis, TERT Promotor Mutations, and Histological Anaplastic Pleomorphic Xanthoastrocytoma-Like Appearance Classify as Mesenchymal Type of Glioblastoma, IDH-wildtype by Methylation Analysis.

Diffusely Infiltrating Gliomas With Poor Prognosis, TERT Promotor Mutations, and Histological Anaplastic Pleomorphic Xanthoastrocytoma-Like Appearance Classify as Mesenchymal Type of Glioblastoma, IDH-wildtype by Methylation Analysis.

Journal: Neurosurgery practice

Published: October 18, 2022

Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide.

Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide.

Journal: Cancers

Published: December 22, 2021

Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of "False-Positive" Cases.

Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of "False-Positive" Cases.

Journal: Diagnostics (Basel, Switzerland)

Published: October 26, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026